Improving mCRPC Outcomes Using Radiopharmaceuticals: Evidence to Implementation +++

Improving mCRPC Outcomes Using Radiopharmaceuticals: Evidence to Implementation CME / ABIM MOC Improving mCRPC Outcomes Using Radiopharmaceuticals: Evidence to Implementation Authors: Rana R. McKay, MD, FASCO; Matthew R. Cooperberg, MD, MPH; Sean M. McBride, MD, MPH, MS https://www.medscape.org/viewarticle/1003039?sso=true&impID=7896121&uac=148436CN&src=wnl_tpal_251122_mscpedu Communicating to Enhance Care Through Data and Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition CME / ABIM MOC / CE Communicating to Enhance Care Through Data and Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition Authors: Kelly Shanahan, MD; Sara Tolaney, MD, MPH; Virginia Kaklamani, MD, DSc; Sarah R. Donahue, MPH, NP, AOCNP; Abigail Shockley, PharmD, BCOP https://www.medscape.org/viewarticle/communicating-enhance-care-through-data-and-patient-2025a1000uqi?page=1&sso=true&impID=7896121&uac=148436CN&src=wnl_tpal_251122_mscpedu Thymidine Kinase 2 Deficiency: Entering a New Era of Treatment to Improve Quality of Life and Survival CME / ABIM MOC Thymidine Kinase 2 Deficiency: Entering a New Era of Treatment to Improve Quality of Life and Survival Authors: Fernando Scaglia, MD, FACMG; Austin Larson, MD; Michio Hirano, MD https://www.medscape.org/viewarticle/thymidine-kinase-2-deficiency-entering-new-era-treatment-2025a1000wek?page=1&sso=true&impID=7896121&uac=148436CN&src=wnl_tpal_251122_mscpedu